Cargando…
A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis
Recombinant proteins are ubiquitously applied in fields like research, pharma, diagnostics or the chemical industry. To provide the full range of useful proteins, novel expression hosts need to be established for proteins that are not sufficiently produced by the standard platform organisms. Unconve...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784666/ https://www.ncbi.nlm.nih.gov/pubmed/35083222 http://dx.doi.org/10.3389/fcell.2021.816335 |
_version_ | 1784638791202373632 |
---|---|
author | Philipp, Magnus Hussnaetter, Kai P. Reindl, Michèle Müntjes, Kira Feldbrügge, Michael Schipper, Kerstin |
author_facet | Philipp, Magnus Hussnaetter, Kai P. Reindl, Michèle Müntjes, Kira Feldbrügge, Michael Schipper, Kerstin |
author_sort | Philipp, Magnus |
collection | PubMed |
description | Recombinant proteins are ubiquitously applied in fields like research, pharma, diagnostics or the chemical industry. To provide the full range of useful proteins, novel expression hosts need to be established for proteins that are not sufficiently produced by the standard platform organisms. Unconventional secretion in the fungal model Ustilago maydis is an attractive novel option for export of heterologous proteins without N-glycosylation using chitinase Cts1 as a carrier. Recently, a novel factor essential for unconventional Cts1 secretion termed Jps1 was identified. Here, we show that Jps1 is unconventionally secreted using a fusion to bacterial β-glucuronidase as an established reporter. Interestingly, the experiment also demonstrates that the protein functions as an alternative carrier for heterologous proteins, showing about 2-fold higher reporter activity than the Cts1 fusion in the supernatant. In addition, Jps1-mediated secretion even allowed for efficient export of functional firefly luciferase as a novel secretion target which could not be achieved with Cts1. As an application for a relevant pharmaceutical target, export of functional bi-specific synthetic nanobodies directed against the SARS-CoV2 spike protein was demonstrated. The establishment of an alternative efficient carrier thus constitutes an excellent expansion of the existing secretion platform. |
format | Online Article Text |
id | pubmed-8784666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87846662022-01-25 A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis Philipp, Magnus Hussnaetter, Kai P. Reindl, Michèle Müntjes, Kira Feldbrügge, Michael Schipper, Kerstin Front Cell Dev Biol Cell and Developmental Biology Recombinant proteins are ubiquitously applied in fields like research, pharma, diagnostics or the chemical industry. To provide the full range of useful proteins, novel expression hosts need to be established for proteins that are not sufficiently produced by the standard platform organisms. Unconventional secretion in the fungal model Ustilago maydis is an attractive novel option for export of heterologous proteins without N-glycosylation using chitinase Cts1 as a carrier. Recently, a novel factor essential for unconventional Cts1 secretion termed Jps1 was identified. Here, we show that Jps1 is unconventionally secreted using a fusion to bacterial β-glucuronidase as an established reporter. Interestingly, the experiment also demonstrates that the protein functions as an alternative carrier for heterologous proteins, showing about 2-fold higher reporter activity than the Cts1 fusion in the supernatant. In addition, Jps1-mediated secretion even allowed for efficient export of functional firefly luciferase as a novel secretion target which could not be achieved with Cts1. As an application for a relevant pharmaceutical target, export of functional bi-specific synthetic nanobodies directed against the SARS-CoV2 spike protein was demonstrated. The establishment of an alternative efficient carrier thus constitutes an excellent expansion of the existing secretion platform. Frontiers Media S.A. 2022-01-10 /pmc/articles/PMC8784666/ /pubmed/35083222 http://dx.doi.org/10.3389/fcell.2021.816335 Text en Copyright © 2022 Philipp, Hussnaetter, Reindl, Müntjes, Feldbrügge and Schipper. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Philipp, Magnus Hussnaetter, Kai P. Reindl, Michèle Müntjes, Kira Feldbrügge, Michael Schipper, Kerstin A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis |
title | A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis
|
title_full | A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis
|
title_fullStr | A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis
|
title_full_unstemmed | A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis
|
title_short | A Novel Potent Carrier for Unconventional Protein Export in Ustilago maydis
|
title_sort | novel potent carrier for unconventional protein export in ustilago maydis |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784666/ https://www.ncbi.nlm.nih.gov/pubmed/35083222 http://dx.doi.org/10.3389/fcell.2021.816335 |
work_keys_str_mv | AT philippmagnus anovelpotentcarrierforunconventionalproteinexportinustilagomaydis AT hussnaetterkaip anovelpotentcarrierforunconventionalproteinexportinustilagomaydis AT reindlmichele anovelpotentcarrierforunconventionalproteinexportinustilagomaydis AT muntjeskira anovelpotentcarrierforunconventionalproteinexportinustilagomaydis AT feldbruggemichael anovelpotentcarrierforunconventionalproteinexportinustilagomaydis AT schipperkerstin anovelpotentcarrierforunconventionalproteinexportinustilagomaydis AT philippmagnus novelpotentcarrierforunconventionalproteinexportinustilagomaydis AT hussnaetterkaip novelpotentcarrierforunconventionalproteinexportinustilagomaydis AT reindlmichele novelpotentcarrierforunconventionalproteinexportinustilagomaydis AT muntjeskira novelpotentcarrierforunconventionalproteinexportinustilagomaydis AT feldbruggemichael novelpotentcarrierforunconventionalproteinexportinustilagomaydis AT schipperkerstin novelpotentcarrierforunconventionalproteinexportinustilagomaydis |